Plasseraud Ip opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Plasseraud Ip

Patent Number:
Title:
Systems And Methods For Automated Analysis
Opposition Date:
Jan 26, 2023
Patent Number:
Title:
Nicotinamide Mononucleotide Derivatives And Their Uses
Opposition Date:
Nov 17, 2021
Patent Number:
Title:
Use Of Chimeric Antigen Receptor-Modified T Cells To Treat Cancer
Opposition Date:
Jul 3, 2019

Want to track Plasseraud Ip?

Feel free to send us a message here and we will get back to you